David S. Grayzel, Director at Aerovate Therapeutics, Inc. (AVTE), sold 23,764 shares at $28.15 ($669K) on 2024-04-09, disclosed to the SEC on 2024-04-11.
Open-market sale of $669k AVTE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.15 | 11,882 | $334K | 50.0% |
| 2 | $28.15 | 11,882 | $334K | 50.0% |
| Total | $28.15 avg | 23,764 | $669K | 100% |
| Filing → |
| SURF | SELL | 2020-12-21 | $13.8M | — | Filing → |
| SURF | BUY | 2018-04-23 | $1.5M | — | Filing → |